Cargando…
Autologous Stem Cell Transplantation in elderly Acute Myeloid Leukemia
Treatment outcome in elderly Acute Myeloid Leukemia (AML) is still very disappointing. Although complete remission rate is around 50–60% the 2 years survival is only in the magnitude of 10–20%. This is mainly due to an overrepresentation of adverse prognostic factors present in elderly AML. As relap...
Autores principales: | Ossenkoppele, Gert J, Janssen, Jeroen JWM, Huijgens, Peter C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591258/ https://www.ncbi.nlm.nih.gov/pubmed/23505606 http://dx.doi.org/10.4084/MJHID.2013.018 |
Ejemplares similares
-
History and Development of Autologous Stem Cell Transplantation for Acute Myeloid Leukemia
por: Gorin, Norbert Claude
Publicado: (2021) -
Acute myeloid leukemia
por: Ossenkoppele, Gert
Publicado: (2018) -
Older Patients with Acute Myeloid Leukemia Deserve Individualized Treatment
por: de Leeuw, David C., et al.
Publicado: (2022) -
Is There Still a Role for Autologous Stem Cell Transplantation for the Treatment of Acute Myeloid Leukemia?
por: Ferrara, Felicetto, et al.
Publicado: (2019) -
Clinical value of new drugs in acute myeloid leukemia
por: Ossenkoppele, Gert
Publicado: (2019)